Mobix Labs, Inc. has been added to the Russell Microcap Index and the Russell 3000E Growth Benchmark, effective with the market open on June 29, 2026. This inclusion is part of the 2026 Russell indexes reconstitution. The company believes this milestone expands its visibility across institutional, index-fund, ETF, and global investor audiences, potentially enhancing investor exposure.

The addition to the Russell Microcap Index automatically secures Mobix Labs a position in the Russell 3000E Index. The Russell 3000E Index provides the broadest coverage of investable US equities, extending the company’s reach to a wider investment base. Russell indexes are widely used by institutional investors and investment managers, with approximately $12 trillion in assets benchmarked to or invested in products tracking Russell U.S. indexes.

The Russell Microcap Index tracks the performance of the smallest 1,000 securities in the Russell 3000 Index, plus the next 1,000 smallest securities. The annual reconstitution process ensures the indexes accurately reflect the current market landscape.

Mobix Labs, Inc. trades on the Nasdaq under the ticker symbol MOBX.

Mobix Labs, Inc. (NASDAQ: MOBX) has terminated its equity line of credit offering and is filing a post-effective amendment to deregister approximately 900,000 shares previously registered for potential sale. The company stated that this decisive action removes a potential source of future dilution and simplifies its capital markets profile.

The shares in question were never issued and will not be issued under the terminated equity line of credit. Mobix Labs indicated that the decision reflects its continued focus on disciplined capital management and long-term stockholder value.

Key Details

The company’s management emphasized that simplifying the capital structure aligns with its strategy for long-term value creation. By removing the possibility of these shares entering the market, Mobix Labs aims to protect existing stockholder interests.